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Abstract: In our continuous interest to study the diversity of halogenated metabolites of 
Malaysian  species  of  the  red  algal  genus  Laurencia,  we  examined  the  chemical 
composition of five populations of unrecorded Laurencia sp. A new brominated diterpene,  
10-acetoxyangasiol (1), and four other known metabolites, aplysidiol (2), cupalaurenol (3), 
1-methyl-2,3,5-tribromoindole  (4),  and  chamigrane  epoxide  (5),  were  isolated  and 
identified.  Isolated  metabolites  exhibited  potent  antibacterial  activities  against  clinical 
bacteria, Staphylococcus aureus, Staphylococcus sp., Streptococcus pyogenes, Salmonella 
sp. and Vibrio cholerae. 
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1. Introduction 
Red algae of the genus Laurencia (Rhodomelaceae, Ceramiales) are known to be prolific sources of 
a  wide  variety  of halogenated secondary metabolites, such as C15-acetogenins and C15-, C20-, and  
C30-terpenoids [1]. In the course of our chemical and biological investigation of Laurencia species 
from the coastal waters of Borneo (Malaysia), we reported the chemical composition of L. snackeyi 
(Weber-van Bosse) Masuda [2], L. similis Nam et Saito [3], and L. majuscula (Harvey) Lucas [4,5]. As 
part of the chemical analysis of the undescribed Laurencia species, we examined five populations of 
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unrecorded  Laurencia  sp.  collected  from  the  coastal  waters  of  North  Borneo  Island,  Sabah.  Each 
specimen contained one halogenated metabolite, a total of five halogenated metabolites were isolated 
and identified. These specimens yielded one new 10-acetoxyangasiol (1) and four known halogenated 
metabolites;  aplysiadiol  (2),  cupalaurenol  (3),  1-methyl-2,3,5-tribromoindole  (4),  and  chamigrane 
epoxide (5). The structure of the new compound 10-acetoxyangasiol (1) was elucidated by spectral 
data. The structures of the known metabolites (2–5) were determined based on the comparison of 
spectral data to that of the published reports of Ojika et al. [6,7], Ichiba and Higa [8] and Carter and 
Rinehart [9]. In this paper, we describe the isolation and structure elucidation of these compounds and 
their antibacterial activities against clinical bacteria. 
Figure 1. The structure of compounds 1–5 from specimens of algae Laurencia sp. 
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2. Results and Discussion 
The  partially  dried  specimens  of  algae  Laurencia  sp.  were  extracted  in  MeOH  (1:1,  v/v).  The 
concentrated  extracts  were  partitioned  between H2O and EtOAc. The EtOAc soluble fraction was 
dehydrated over Na2SO4 anhydrous, filtered, concentrated and purified by a combination of silica gel 
column chromatography and High Performance Liquid Chromatography (HPLC) separation, to yield 
compounds 1–5 (Figure 1). 
Compound 1 was obtained as white powder, []
25
D +6.4 (c 0.9, CHCl3). The IR spectrum indicated 
the presence of OH group (3532 cm
–1), -lactone carbonyl group (1773 cm
–1) and acetoxy functionality 
(1734  and  1236  cm
–1).  The  positive  ESI-MS  exhibited  a  characteristic  molecular-ion  cluster  at  
m/z 535/537/539 in a ratio of 1:2:1, suggesting the presence of two bromine atoms. The molecular 
formula  was  determined  to  be  C22H32Br2O5  by  HR-ESI-TOFMS,  indicating  six  degrees  of 
unsaturation.  The 
13C  NMR  spectrum  (Table  1)  along  with  the  DEPT  experiments  showed  the 
presence of 22 carbons including four methyls, seven methylenes, five methines and six quaternary 
carbon atoms. In addition, the 
1H and 
13C NMR spectral data (Table 1) indicated the presence of a  
-lactone  carbonyl  group  [C  174.3  (s)]  and  an  associated  tertiary  alkoxy  group  [C  83.0  (s)],  an 
acetoxy group [C 169.4 (s), 20.2 (q); H 1.58 (3H, s)], an acetoxymethine [C 83.0 (d); H 4.31 (1H, d, Mar. Drugs 2010, 8                     
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J  = 8.9  Hz)],  a  tertiary  alcohol  [C  73.7  (s)],  two  bromomethines  [C 64.4 (d);  H 3.52 (1H, dd,  
J = 13.1, 4.1 Hz) and C 51.0 (d); H 3.33 (1H, dd, J = 11.7, 6.2 Hz)] and three tertiary methyls  
[H 1.25, 1.15 and 0.93 (each 3H, s)]. According to the molecular formula and the functionalities 
mentioned  above,  compound  1  is  suggested  to  contain  one  -lactone  and  three  carbocyclic  rings. 
Furthermore, the 
13C-NMR spectra of 1 closely resembled those of the known compound angasiol 
[10], except for the absence of one acetoxy group. It clearly  suggested that 1 possesses the same 
skeleton and substituent. 
Table 1. 
1H-NMR and 
13C-NMR spectral data of compound 1 (recorded at 600/150 MHz 
in CDCl3;  in ppm, J in Hz). 
C 
13C () 
1H ()  Multiplicity (J in Hz) 
1  51.0  3.33  (dd, 11.7, 6.2) 
2  32.6  2.00  m 
    1.82  m 
3  38.1  1.32–1.39  m 
    0.81  (ddd, 13.7, 12.4, 5.5) 
4  83.0     
5  60.1  1.34  (d, 8.3) 
6  38.0  2.32  (dddd, 11.0, 8.9, 8.3, 4.8) 
7  29.6  1.50–1.57  m 
    1.05  (dddd, 14.5, 10.3, 4.8, 2.0) 
8  32.7  2.54  (ddd, 13.1, 8.3, 2.0) 
    1.43  (ddd, 13.1, 10.3, 10.3) 
9  61.8     
10  83.0  4.31  (d, 8.9) 
11  73.7     
12  34.3  0.90–0.95  m 
    0.56  (ddd, 13.1, 13.1, 4.1) 
13  29.7  2.25  (dddd, 13.1, 13.1, 13.1, 3.4) 
    1.78  (dddd, 13.1, 4.1, 4.1, 4.1) 
14  64.4  3.52  (dd, 13.1, 4.1) 
15  36.1     
16  47.2  1.29  (dd, 13.7, 3.4) 
    0.92  (d, 13.7) 
17  21.9  1.15  s 
18  174.3     
19  22.7  1.25  s 
20  32.3  0.93  s 
Ac  169.4     
  20.2  1.58  s 
Assignments  were  carried  out  based  on 
1H-
1H  COSY,  HSQC  and  HMBC  spectra  data.  
1H-
1H COSY experiments revealed the sequences of the correlations depicted by the bold lines in 
Figure 2. Key HMBC correlations as shown in Figure 2 were consistent with the proposed structure of 
1. Furthermore, the relative stereochemistry of 1 was elucidated by NOESY experiments as well as the Mar. Drugs 2010, 8                     
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coupling constants in the 
1H-NMR spectrum. The coupling constant (J6,10 = 8.9 Hz) indicated the anti 
conformation for the H-6/H-10. The configuration at C-10 was assigned as R* on the basis of the 
NOESY  correlations  observed  between  H-5/H-10,  H-7/H-10,  H-10/Hax-12,  H-10/Hax-16  and  
H3-17/H3-Ac. In addition, the remaining stereochemistry of 1 was determined by NOESY correlations 
as shown in Figure 3 and assigned to be the same as for angasiol and its related compounds, irieols  
A–G  [10–12].  In  consequence,  the  structure  of  10-acetoxyangasiol  (1)  must  be  represented  by  
structure 1. 
All five metabolites were subjected to antibacterial bioassay against five species of clinical bacteria, 
and their antibacterial activities at 30 mg disc
-1are shown in Table 2. Compounds 1, 2 and 3 exhibited 
potent  inhibition  against  three  of  the  tested  bacteria.  The  lowest  MIC  value  was  observed  for 
compound  1  against  Vibrio  cholerae  at  100  g  mL
-1.  Compounds  4  and  5  only  exhibited  weak 
inhibition  against  Staphylococcus  sp.  with  a  MIC  value  of  300  g  mL
-1.  Vancomycin,  used  as  a 
positive control, exhibited a >23 mm inhibition zone against all the tested microbes at 30 mg disc
-1. 
Based on our findings, these halogenated metabolites could be considered as possible candidates for 
further  investigation  against  clinical  microbes  in  our  endeavor  to  combat  the  rise  in  antibiotic  
resistant microbes. 
Figure 2. 
1H-
1H COSY correlations (bold lines) and key HMBC correlations (H→C) of 1. 
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Figure 3. NOESY correlations of 1. 
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Table 2. Diameter of inhibition zone (DIZ) and minimum inhibitory concentration (MIC) 
of halogenated metabolites from Laurencia sp against five bacteria. 
Tested Bacteria  Halogenated Metabolites 
1  2  3  4  5 
INHIBITION AT 30 mg/disc (mm)           
Staphylococcus aureus  10  8  15  -  - 
Staphylococcus sp.  12  10  15  9  9 
Streptococcus pyogenes  -  -  -  -  - 
Salmonella sp.  -  9  15  -  - 
Vibrio cholerae  18  -  11  -  - 
MINIMUM INHIBITION CONCENTRATION (MIC) (g/mL)           
Staphylococcus aureus  250  200  125  -  - 
Staphylococcus sp.  200  125  125  300  300 
Streptococcus pyogenes  -  -  -  -  - 
Salmonella sp.  -  250  125  -  - 
Vibrio cholerae  100  -  200  -  - 
Note: Bioassay were done in triplicate, SD <10%, and not shown. 
3. Experimental Section 
3.1. General 
Optical rotations were measured on an AUTOPOL IV automatic polarimeter (Rudolph Research 
Analytical). 
1H-NMR (600 MHz) and 
13C-NMR (150 MHz) spectra were recorded with a JEOL ECA 
600, with TMS as internal standard. HR-ESI-TOFMS spectrum was obtained with LCMS-IT-TOF 
(Shimadzu). Silica gel (Merck, Kieselgel 60, 70–230 mesh) was used for column chromatography. 
Separation  of  the  eluted  fraction  were  carried  out  using  Shimadzu  HPLC  with  Phenyl  Hexyl 
(Phenomenex, USA) 10 x 250 mm eluted with 70% MeCN/H2O, and detected at 210 nm using SPD 
20A Shimadzu UV-Vis detector. Analytical TLC was performed on Merck Kieselgel 60 F254. Spots 
were visualized by UV light or by spraying with a 5% phosphomolybdic acid-ethanol solution. 
3.2. Algal material 
Specimens of Laurencia sp. were collected from Lohok Butun (427’23”N, 11841’12”E), Selakan 
Island  (435’00”N,  11842’04”E),  Layangan  Island  (546’63”N,  11553’39”E),  and  Gaya  Island 
(600’47”N, 11603’14”E). The specimens (voucher nos. 37604, 37610, 37665, 37767, 37774) are 
deposited in the Herbarium (BORH) of Institute for Tropical Biology and Conservation, Universiti 
Malaysia Sabah. 
3.3. Extraction and isolation 
The partially dried alga specimens (100 g) were extracted with MeOH. The MeOH solution was 
concentrated in vacuo and partitioned between EtOAc and H2O. The EtOAc fraction was washed with 
water, dried over anhydrous Na2SO4, and evaporated to leave dark green oil. The extract was then 
fractioned by Si gel column chromatography with a step gradient (hexane and EtOAc). The fractions Mar. Drugs 2010, 8                     
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eluted with hexanes-EtOAc (9:1) and hexanes-EtOAc (8:2) were further purified by HPLC to give  
10-acetoxyangasiol (1) (2.4%) from specimen BORH 37610, aplysidiol (2) (3.2%) from specimen 
BORH 37665), cupalaurenol (3) (0.9%) from specimen BORH 37774, 1-methyl-2,3,5-tribromoindole 
(4) (2.8%) from specimen BORH 37767, and chamigrane epoxide (5) (3.6%) from specimen BORH 
37774. Yield was calculated based on the extracted methanol crude. 
3.4. Characterization of 10-acetoxyangasiol (1) 
White powder; []
25
D +6.4 (c 0.9, CHCl3); HR-TOFMS m/z 535.0661 [M + H]
+ (calculated for 
C22H33Br2O5, 535.0689); 
1H-NMR and 
13C-NMR spectral data: see Table 1. 
3.5. Bioassay 
The antibacterial bioassay for the isolated metabolite was carried out against 5 species of clinical 
pathogens obtained from Department of Pathology, Queen Elizabeth Hospital, Kota Kinabalu, Sabah, 
Malaysia. These bacteria are Staphylococcus aureus (UMS01-08), Staphylococcus sp. (UMS02-08), 
Streptococcus pyogenes(UMS03-08), Salmonella sp. (UMS04-08) and Vibrio cholerae(UMS05-08). 
One loopful of each organism was precultured in 20 mL of peptone water overnight. The turbidity of 
the  culture  was  adjusted  to  an  optical  density  (OD)  of  McFarland  0.5  [13].  Then  0.1  mL  of  the 
precultured bacterial suspension was used to seed Nutrient Agar plates. Paper discs (Whatman, 6 mm) 
impregnated with 30 mg disc
-1 of the respective isolated compounds were placed on the seeded agar 
plates  and  the  diameter  of  the  inhibitory  zones  measured  after  incubation  at  28  C  for  24  h. 
Antibacterial  activity  was  evaluated  by  measuring  the  diameter  of  inhibition  zone  of  the  tested 
bacteria.  Vancomycin  (Sigma,  Germany)  was  used  as  positive  control.  Minimum  Inhibitory 
Concentration (MIC) determination for the positive inhibitions was carried out via microdilution broth 
method as described by Shan et al. (2008) with slight modifications [14]. 
4. Conclusions 
This  is  our  first  report  on  the  composition  of  halogenated  metabolites  and  their  activities  in 
unrecorded Laurencia sp. from the coastal waters of North Borneo Island of Sabah, Malaysia. Our 
initiative  pertaining  to  the  isolation  and  identification  of  halogenated  secondary  metabolites  from 
Borneon  Laurencia  continues  to  excite  us,  with  the  isolation  of  a  wide  diversity  of  structurally 
interesting  metabolites.  To  date,  we  have  isolated  a  total  of  42  halogenated  metabolites  from  
L. snackeyii, L. majuscula, L. similis, L. nangii and these five species of undescribed Laurencia spp. 
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